ProShares Ultra Nasdaq Biotechnology Rating $46.31 -1.15 (-2.42%) Closing price 03:59 PM EasternExtended Trading$46.27 -0.04 (-0.08%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.74Holdings in BIB have an aggregate rating of Moderate Buy based on 689 analyst ratings issued in the past year covering 44 companies (57.9% of the portfolio).BIB Aggregate Price Target$46.31High Prediction$46.31Average Prediction$46.31Low Prediction$46.31Holdings in BIB have an aggregate price target of $46.31 and a range of $46.31 to $46.31 covering 44 companies (57.9% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.73%VRTXVertex Pharmaceuticals$498.86-2.1%3.9399 of 5 stars2.64$514.91 3.2%25Upcoming EarningsAnalyst RevisionPositive News6.10%GILDGilead Sciences$103.25-3.1%4.7136 of 5 stars2.78$110.55 7.1%27Earnings ReportDividend AnnouncementAnalyst Revision5.92%AMGNAmgen$283.78-2.5%4.0738 of 5 stars2.43$310.57 9.4%23Earnings ReportPositive News5.17%REGNRegeneron Pharmaceuticals$590.00-1.5%4.8264 of 5 stars2.88$892.60 51.3%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.26%AZNAstraZeneca$70.51-1.8%2.8886 of 5 stars3.10$88.00 24.8%10Earnings ReportShort Interest ↓Analyst RevisionPositive News2.56%ALNYAlnylam Pharmaceuticals$255.13-3.1%4.2169 of 5 stars2.77$315.58 23.7%26Earnings ReportAnalyst DowngradePositive News2.00%SMMTSummit Therapeutics$24.67+2.3%2.6793 of 5 stars3.00$37.50 52.0%10Earnings ReportAnalyst ForecastAnalyst Revision1.56%ARGXargenx$639.90-0.8%2.4982 of 5 stars2.91$699.28 9.3%23Upcoming EarningsPositive News1.41%BIIBBiogen$120.93-0.1%4.6953 of 5 stars2.38$201.93 67.0%32Earnings ReportAnalyst DowngradeAnalyst RevisionNews Coverage1.25%SNYSanofi$54.10-1.5%3.7746 of 5 stars3.14$63.33 17.1%7Earnings ReportAnalyst UpgradeAnalyst RevisionPositive News1.12%RPRXRoyalty Pharma$32.48-1.0%4.3599 of 5 stars3.00$42.50 30.8%5Upcoming EarningsPositive News1.08%UTHRUnited Therapeutics$293.85-3.0%4.9872 of 5 stars2.67$392.00 33.4%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive News1.05%INSMInsmed$72.64+0.9%4.3531 of 5 stars3.00$94.00 29.4%16Upcoming EarningsNews CoveragePositive News0.99%ILMNIllumina$76.51-1.4%4.6932 of 5 stars2.48$137.55 79.8%21Upcoming EarningsAnalyst ForecastPositive News0.97%BMRNBioMarin Pharmaceutical$62.71-1.5%4.9249 of 5 stars2.70$93.14 48.5%23Positive News0.93%BNTXBioNTech$102.43-1.7%2.551 of 5 stars2.89$143.44 40.0%18Upcoming Earnings0.92%INCYIncyte$62.03-1.0%4.7158 of 5 stars2.17$73.53 18.5%18Earnings ReportAnalyst Forecast0.85%ONCBeigene$255.64-1.6%2.0064 of 5 stars3.00$318.88 24.7%6Analyst ForecastAnalyst Revision0.84%MRNAModerna$27.03-5.3%4.431 of 5 stars2.04$58.70 117.2%24Earnings ReportNews CoverageHigh Trading Volume0.84%NBIXNeurocrine Biosciences$106.59-1.0%4.8696 of 5 stars2.86$160.90 51.0%22Upcoming EarningsAnalyst ForecastAnalyst Revision0.84%EXELExelixis$38.89-0.7%4.0707 of 5 stars2.47$37.59 -3.3%19Short Interest ↑Analyst RevisionPositive News0.78%ASNDAscendis Pharma A/S$167.47-1.7%2.3101 of 5 stars2.93$204.67 22.2%15Earnings ReportNews CoveragePositive News0.76%VTRSViatris$8.47+0.6%1.832 of 5 stars1.75$10.50 24.0%4Upcoming Earnings0.72%MEDPMedpace$302.25-2.0%4.3883 of 5 stars2.23$349.30 15.6%13Insider TradeShort Interest ↑0.68%TEMTempus AI$51.85+0.3%2.0464 of 5 stars2.54$61.08 17.8%13Upcoming EarningsGap Up0.63%ROIVRoivant Sciences$11.58-0.3%2.2017 of 5 stars3.00$17.50 51.1%40.59%HALOHalozyme Therapeutics$60.03-2.3%3.9901 of 5 stars2.60$62.89 4.8%10Upcoming EarningsInsider TradeAnalyst RevisionNews Coverage0.57%RVMDRevolution Medicines$40.64+0.6%3.7619 of 5 stars3.00$66.67 64.0%12Upcoming EarningsAnalyst ForecastPositive News0.56%MDGLMadrigal Pharmaceuticals$327.70-1.9%3.745 of 5 stars3.00$409.00 24.8%9Earnings ReportNews CoveragePositive NewsGap UpHigh Trading Volume0.55%BBIOBridgeBio Pharma$38.40+0.1%4.5542 of 5 stars2.92$57.09 48.7%12Earnings ReportAnalyst ForecastOptions VolumeNews CoverageHigh Trading Volume0.52%JAZZJazz Pharmaceuticals$117.18+0.2%4.8002 of 5 stars2.93$187.71 60.2%14Upcoming EarningsAnalyst RevisionNews Coverage0.47%SRPTSarepta Therapeutics$62.78+0.6%4.7399 of 5 stars2.83$158.70 152.8%24Upcoming Earnings0.46%GHGuardant Health$48.87+3.5%3.946 of 5 stars3.05$51.64 5.7%22Analyst ForecastNews CoverageGap UpHigh Trading Volume0.45%BPMCBlueprint Medicines$99.25+10.9%2.5602 of 5 stars2.68$124.53 25.5%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsHigh Trading Volume0.42%ADMAADMA Biologics$23.27-2.2%1.4633 of 5 stars3.25$22.50 -3.3%4Upcoming EarningsOptions VolumeNews CoveragePositive NewsGap Up0.42%AXSMAxsome Therapeutics$112.240.0%4.832 of 5 stars3.00$169.87 51.3%16Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News0.41%VRNAVerona Pharma$72.26+0.3%2.9026 of 5 stars3.11$81.50 12.8%9Earnings ReportAnalyst ForecastInsider TradeShort Interest ↓Analyst RevisionNews CoveragePositive News0.39%KRYSKrystal Biotech$165.69-2.5%4.9058 of 5 stars3.00$222.71 34.4%8Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoveragePositive News0.39%NUVLNuvalent$76.23-0.7%1.8882 of 5 stars2.90$115.50 51.5%10Upcoming EarningsPositive NewsHigh Trading Volume0.38%IONSIonis Pharmaceuticals$31.71+3.3%4.2666 of 5 stars2.65$56.67 78.7%20Earnings ReportAnalyst ForecastNews CoveragePositive News0.37%CYTKCytokinetics$42.92+0.2%4.1714 of 5 stars2.94$79.13 84.4%18Upcoming EarningsInsider Trade0.36%ALKSAlkermes$30.58+6.3%4.2568 of 5 stars2.58$38.08 24.5%12Earnings ReportAnalyst ForecastNews Coverage0.35%PCVXVaxcyte$35.24-1.7%3.0309 of 5 stars3.10$136.50 287.3%10Upcoming EarningsPositive NewsHigh Trading Volume0.32%PTCTPTC Therapeutics$49.52-0.6%4.0687 of 5 stars2.53$63.92 29.1%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News This page (NASDAQ:BIB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIB Stock Free BIB Stock Alerts